Inotuzumab Ozogamicin - PF-05208773

Status

APPROVED_FOR_MARKETING

Phases

Unknown

Study type

Expanded Access

Source

ClinicalTrials.gov

Registry ID

NCT03127605

Enrollment

Unknown

Registered

2017-04-25

Start date

Unknown

Completion date

Unknown

Last updated

2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Inotuzumab Ozogamicin Expanded Access Program

DRUGInotuzumab Ozogamicin

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026